baber/WOPTO huggingface dataset:
Patent ES-2209407-T3 (ES)
Title: Lampara de haluro metalico.
Inventor: SUIJKER JOSEPH L G
IPC: H01J61/24
Filed: 1999-03-29
Granted: 2004-06-16
Abstract: La invención se refiere a una lámpara de haluro metálico que comprende un recipiente de descarga con una pared de cerámica, encerrando el recipiente de descarga un espacio de descarga que contiene una sustancia de relleno ionizable cuyo relleno contiene una cantidad de ioduro de Na y de T1, además de Hg. Según la invención, la sustancia de relleno ionizable también contiene Ca y carece de haluros de tierras raras y, además, el recipiente de descarga contiene un dispensador de oxígeno.
Patent ES-2255259-T3 (ES)
Title: Utilizacion de celulas derivadas de monocitos, antigenos y anticuerpos para la induccion optima de eficacia inmunoterapeutica.
Inventor: BARTHOLEYNS JACQUES
IPC: C12Q1/02
Filed: 1999-03-29
Granted: 2006-06-16
Abstract: Procedimiento para la preparación de células derivadas de monocitos que presentan epítopes antigénicos en sus membranas tras la interiorización y procesamiento de por lo menos un complejo antígeno-anticuerpo formado entre un antígeno y un anticuerpo, siendo dicho anticuerpo exclusivamente un anticuerpo no biespecífico, y comprendiendo dicho procedimiento las etapas siguientes: a)preparación de las células derivadas de monocitos según el método siguiente: 1) recuperación de células mononucleares derivadas de sangre directamente de aféresis sanguínea o de recolección de bolsas de sangre, seguida, en caso necesario, por centrifugación, para eliminar una parte sustancial de glóbulos rojos, granulocitos y plaquetas, y recolección de leucocitos de sangre periférica; 2) lavado de los leucocitos de sangre periférica obtenidos en las etapas anteriores, por ejemplo por centrifugación, para eliminar el 90% de las plaquetas, glóbulos rojos y desechos para obtener células mononucleares; 3) resuspensión de las células mononucleares totales obtenidas en las etapas anteriores en un medio de cultivo, como AIMV, RPMI o IMDM entre 106 y
Patent ES-2328755-T3 (ES)
Inventor: DIJKMAN HENDRIK
IPC: C02F3/34
Filed: 1999-07-13
Granted: 2009-11-17
Abstract: A process is described for the biological treatment of waste water containing ammonia, wherein the waste water is treated with sludge containing nitrifying bacteria in an aerated reactor, applying a sludge retention time in the reactor which favours nitrite-producing bacteria over nitrate-producing bacteria. The process is characterised by applying a hydraulic retention time in a continuously operated reactor, which is shorter than the sludge retention time as a result of part of the sludge being separated from the reactor effluent and being returned to the reactor. The performance of the nitrification is further improved by applying low oxygen and nitrite concentrations.
Patent ES-2185376-T3 (ES)
Inventor: ARAIDA YASUROU
IPC: C09J7/04
Filed: 1999-07-10
Granted: 2003-04-16
Abstract: Use of a metallocene-polyethylene nonwoven as backing material, the said backing material being provided on at least one side with a self-adhesive coating.
Patent ES-2211185-T3 (ES)
Inventor: SPRENGER PETER
IPC: B68B1/06
Filed: 1999-08-13
Granted: 2004-07-01
Abstract: The snaffle bit for a horse has two side rings and a shackle arranged between the two side rings. The shackle is provided with tow side portions and has at least one joint. The at least one joint defines an articulation axis. A bore is arranged in the end area of each of the side portions that is remote from the at least one joint and receives with play a respective one of the two side rings. The axes of the two bores defines a plane that is inclined at an angle of 45°±20°, preferably of 45°±10°, to the articulation axis of the at least one joint.
Patent ES-2312218-T3 (ES)
Inventor: SLOOTSTRA JELLE WOUTER
IPC: G01N33/15
Filed: 1999-11-15
Granted: 2009-02-16
Abstract: The invention relates to a method for determining a mimotope sequence for a receptor comprising the steps of: a) providing a library of test sequences; b) determining the activity of each test sequence of the library towards the receptor; c) identifying a test sequence comprising at a certain position a building block which, according to the results of step b) is favored at said position; d) providing a next library of test sequences, based on said test sequence identified in step c), by replacing a building block at selected positions of the identified test sequence with selected building blocks; e) determining the activity of each test sequence of the library provided in step d) towards the receptor; f) identifying a test sequence comprising at a certain position a building block which, according to the results of step e), is favored at said position; g) repeating steps d) - f) for the library of test sequences provided in step d), for a number of cycles sufficient for finding in step f) a mimotope sequence that gives sufficient activity towards the receptor.
Patent ES-2205938-T3 (ES)
Inventor: SHAFER TERRY
IPC: F16K5/06
Filed: 1999-12-21
Granted: 2004-05-01
Abstract: A valve assembly including a valve housing having a fluid passageway extending through it. The fluid passageway has an inlet portion having a cross-section defined by a substantially annular inlet surface, an outlet portion having a cross-section defined by a substantially annular outlet surface, and an inner chamber portion defined by a substantially annular inner chamber surface, an inner wall, and an outer wall. The inner wall extends inwardly from the inner chamber surface to the inlet surface, and the outer wall extends inwardly from the inner chamber surface to the outlet surface. The inner chamber portion is positioned between and adjacent to the inlet and outlet portions. A valve member is located within the inner chamber portion and is movable between a closed position in which the fluid passageway is blocked, and an open position in which the fluid passageway is not blocked. First and second substantially annular retainer ring assemblies are also located within the inner chamber portion, and rotatably position the valve member within the inner chamber portion. The first and second retainer ring assemblies provide first and second fluid seals between the valve member and the inner chamber surface at the first and second ends of the inner chamber portion respectively. The first and second retainer ring assemblies each include a floating retainer ring and a plurality of sealing members. The floating retainer rings are movable relative to the valve member, the inner chamber surface, and the inlet and outlet walls.
Patent PL-1678209-T3 (PL)
Title: Antibodies to nik, their preparation and use
Inventor: WALLACH DAVID
IPC: C07K16/40
Filed: 2004-10-05
Abstract: An antibody or antibody fragment preparation being capable of specifically binding the amino acid sequence 60-76, 86-98, 135-149, 215-227, 363-377, 385-397, 405-419, 427-440, 509-522, 605-619, 635-649, 666-680, 696-711, 752-766, 836-851, 871-884, and/or 904-916 of NIK, or being capable of specifically binding a specific portion of the amino acid sequence is provided.
Patent PL-1753813-T3 (PL)
Title: Polyolefin composition having a high balance of stiffness, impact strength and elongation at break and low thermal shrinkage
Inventor: PELLICONI ANTEO
IPC: C08L23/08
Filed: 2005-05-30
Abstract: Polymer composition showing an improved balance of flexural modulus, IZOD impact strength and elongation at break comprising (percent by weight): A) a polymer blend comprising: A1) 50-70% of a crystalline propylene homopolymer or copolymer; and A2) 30-50% of one or more copolymer(s) of ethylene with one or more C4-C10 α-olefin(s) containing from 15 to 35% of said C4-C10 α-olefin(s); said polymer blend (A) having values of MFR equal to or higher than 10 g/10 min., a total content C4-C10 α-olefin(s) equal to or higher than 8% and an intrinsic viscosity value of the fraction soluble in xylene at room temperature of from 1.3 to 2 dl/g, the amounts of (A1) and (A2) being referred to the total weight of the polymer blend; and optionally B) 1-15% of an elastomeric polymer different from A2), having a hardness (Shore A, ASTM D-2240) value equal to or lower than 90 points; and/or C) 0.5-20% of a mineral filler; the amounts of optional components (B) and (C) being referred to the total weight of the composition.
Patent PL-1774145-T3 (PL)
Title: Improved catalyzed soot filter
Inventor: ZIEBARTH ROBIN
IPC: B01J23/04
Filed: 2005-07-26
Abstract: An improved catalyzed soot filter is comprised of a porous ceramic having, on at least a portion of the porous ceramic, an amorphous catalytic phase comprised of an alkali containing oxide glass having therein Si, Al or combination thereof. The improved catalyzed soot filter may be formed by contacting a porous ceramic such as mullite, silcon carbide or cordierite with an alkali containing compound that is a silicate, aluminate or alumino-siliicate and heating to a temperature sufficient to form an amorphous catalytic phase fused to at least a portion of the porous ceramic.
Patent PL-1857605-T3 (PL)
Title: Floor covering for a building part
Inventor: KALMBACH STEFAN
IPC: E04D11/00
Filed: 2006-05-19
Abstract: A floor covering has main profiled sections (MPS) (1) parallel to each other and overlapping on their side walls as well as a coupling profiled section (2) linking the adjacent profiled sections set with a clearance from each other. A locking profiled section works together with an end profiled section so as to adjust. The MPS are designed as flat channels on a floor to be covered.
Patent PL-1840444-T3 (PL)
Title: Process to produce a cladding for a heat insulated conduit
Inventor: RUDI ROBERTO
IPC: B29C48/10
Filed: 2007-03-19
Abstract: Polyethylene-based thermal insulation sleeves (3) for pipes used in district heating systems have a foam structure. They have an E-modulus of 90 - 300 MPa and a density of 0.560 - 0.850 g/cc. An independent claim is included for a method for making the sleeves which comprises mixing: (A) polyethylene granules; and (B) a mixture of polyethylene granules and a blowing agent. The product is fed to an extruder which forms it into a tubular shape. The blowing agent then expands it into a foam tube.
Patent PL-1900362-T3 (PL)
Title: Alfa-aminoamide derivatives useful in the treatment of addictive disorders
Inventor: BESANA CLAUDIA
IPC: A61K31/40
Filed: 2005-04-19
Abstract: Certain ±-aminoamide derivatives for use in the treatment of addictive disorders are disclosed. The compounds of this invention are able to reduce or even stop the symptoms of addictive disorders substantially without side effects.
Patent PL-2079674-T3 (PL)
Title: Process for the preparation of trifluoroethoxytoluenes
Inventor: ZICANE DAINA
IPC: C07C43/205
Filed: 2007-11-02
Abstract: A process for the preparation of Flecainide acetate, its salts, in particular its pharmaceutically acceptable salts, and intermediates thereof is described wherein 2,5-dibromotoluene is used as a starting material. The method involves a technique for preparing the starting material 2,5- bis (2,2,2-trifluroethoxy)toluene in high yields by reacting 2,5-dibromotoluene with 2,2,2-trifluoroethanol in the presence of a base and a copper-containing catalyst.
Patent GR-3003582-T3 (GR)
IPC: C07C275/66
Filed: 1992-01-16
Abstract: A new process of synthesis of optically active  alpha -amino acids is described through nitrosation in a non-aqueous, aprotic system, of the corresponding N-carbamyl derivatives followed by decomposition of the thus obtained N-nitroso derivatives in aqueous acidic medium. The process, which is of a general applicability, leads to a remarkable increase in the reaction yields, due to the suppression of the main side reaction leading to the corresponding  alpha -hydroxy-acid. Some N-nitroso intermediates, which can be recovered from the process of the invention, are also described.
Patent GR-3004576-T3 (GR)
IPC: C07F9/38
Filed: 1992-05-12
Abstract: The invention provides the use of a physiologically compatible chelate complex of a chelating compound and a paramagnetic ion of a lanthanide element having an atomic number in the range 57 to 70 or of a transition metal having an atomic number selected from 21 to 29, 42 and 44 and of a non-paramagnetic organic calcium salt for the preparation of a magnetic resonance imaging contrast medium by admixture of said complex and said organic salt. The admixed calcium serves to enhance the biotolerability of the paramagnetic chelate containing MRI contrast medium.
Patent GR-3006048-T3 (GR)
IPC: A61K47/48
Filed: 1992-10-22
Abstract: The present invention concerns epitope cytotoxic substance conjugates for the treatment or prophylaxis of autoimmune diseases. The conjugate specifically binds to auto-immune T-lymphocytes and eliminates the T-lymphocytes responsible for the auto-immune disease.
Patent GR-3006959-T3 (GR)
IPC: H03G3/34
Filed: 1993-02-03
Abstract: An arrangement for suppressing audible noise occurring when audio equipment is switched on and off, in which a first electronic switch is connected to the output of an amplifier that has a negative feedback loop formed between the amplifier output and an inverting input of the amplifier. The output of the amplifier is connected to a load impedance through the first electronic switch. A second electronic switch is connected to a junction between the load impedance and the first electronic switch, and to the inverting input of the amplifier. A joint control line permits the two electronic switches to be turned on and off simultaneously. The two electronic switches can be connected in parallel through a feedback resistor in the negative feedback loop.
Patent GR-3017467-T3 (GR)
Title: Refastenable mechanical fastening system and process of manufacture therefor.
Inventor: THOMAS DENIS ALBERT
IPC: A61F13/66
Filed: 1995-09-21
Abstract: The invention is a refastenable mechanical fastening system, made of free formed prongs joined to a substrate. The prongs taper and are nonperpendicularly oriented relative to the plane of the substrate. The prongs also have an azimuthal angle relative to the machine direction of the substrate. Each prong has an engaging means projecting laterally from the periphery of the prong. The free formed prongs are manufactured by the process of depositing liquid material onto a moving substrate, stretching the liquid material in a direction parallel to the plane of the substrate, severing the stretched material to form the distal end and engaging means of the prong, and imparting an azimuthal angle to the prong. The advantageous usage of the fastening system in an article of manufacture, such as a disposable absorbant garment, specifically a diaper.
Patent GR-3024457-T3 (GR)
Title: Method and composition for determining the immunological activity of bioactive substances.
Inventor: INGLOT ANNA
IPC: A61K35/10
Filed: 1997-08-14
Abstract: The immunological activity of certain bioactive substances is determined by treating a human peripheral blood leukocyte (PBL) culture or a Bulb/C mice resident peritoneal cells (RPC), such as abdominal membrane macrophage suspension, with a solution of the substance to be tested in order to induce production of cytokines which then are determined according to standard identification methods amplification of the results is achieved by admixing - to the solution to be tested - a non-steroidal anti-inflammatory drug, preferably a substance selected from the group of selenoorganic compounds such as Ebselen (R) of Nattermann (Rhône-Poulenc), indo-methacin and the p-chlorophenyl-amide of 3-methyl-5-benzoyl-amino-isothiazole-4-carboxylic acid.
Patent GR-3024821-T3 (GR)
Title: Anti-lice treatment compositions
Inventor: CARDIN CAROLINE WINYARD
IPC: C11D3/48
Filed: 1997-09-24
Abstract: Ovicidal/pediculicidal anti-lice compositions comprising a mixture of actives wherein the ratio of synthetic pyrethroids to natural pyrethrins is from about 6:1 to about 10:1. Said active mixtures are incorporated into hair treatment compositions, such as shampoos, lotions and conditioners, which are stable at high storage temperatures, effective, safe and easy to use.
Patent GR-3026198-T3 (GR)
Title: Stable extended release oral dosage composition.
Inventor: KWAN HENRY K
IPC: A61P11/00
Filed: 1998-02-23
Abstract: A film-coated extended release oral dosage composition containing the nasal decongestant pseudoephedrine sulfate in a unique polymer matrix core and a film-coating on such core containing the non-sedating antihistamine, loratadine, and use of the said composition for treating patients showing the signs and symptoms associated with upper respiratory diseases and nasal congestion are disclosed.
Patent GR-3027583-T3 (GR)
Title: Catheter for injecting a fluid or medicament
Inventor: HOEFLING BERTHOLD
IPC: A61M25/00
Filed: 1998-08-05
Abstract: An injection catheter including a catheter stem, a cathetertip, and a bundle of injection needles, wherein either the catheter tip is axially displaceable relative to the catheter shaft or the catheter tip is fixedly connected to the catheter stem and the bundle of injection needles is longitudinally displaceable relative to the catheter tip. The catheter tip may take various forms, as the injection needles within the catheter stem may take various forms and may be guided in various ways. An operating device is provided for effecting relative movements between the injection needles and the catheter tip, which operating device comprises two parts that are controllably displaceable relative to one another, thereby to cause the injection needles to be exposed or retracted. The operating device also includes inlets allowing medication to be applied through the injection needles.
Patent GR-3030273-T3 (GR)
Title: INDENO[1,2-e]PYRAZINE-4-ONES, PREPARATION THEREOF AND DRUGS CONTAINING SAME
Inventor: ALOUP JEAN-CLAUDE
IPC: C07D491/147
Filed: 1999-05-27
Abstract: PCT No. PCT/FR95/00357 Sec. 371 Date Sep. 27, 1996 Sec. 102(e) Date Sep. 27, 1996 PCT Filed Mar. 23, 1995 PCT Pub. No. WO95/26349 PCT Pub. Date Oct. 5, 1995The compounds of formula (I)    <IMAGE>  (I)  wherein R, R1 and R2 are defined in the disclosure, and salts thereof. The compounds of formula (I) are non-competitive N-methyl-D-asparate (NMDA) receptor antagonists, particularly NMDA receptor glycine modulation site ligands, and are alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor antagonists, this receptor is also known as the quisqualate receptor.
Patent GR-3031474-T3 (GR)
Title: DNA ENCODING PRECURSOR OF INTERLEUKIN-1-g(b) CONVERTING ENZYME-RELATED CYSTEINE PROTEINASE III (ICE rel?-III)
Inventor: NICHOLSON DONALD W
IPC: A61K48/00
Filed: 1999-10-08
Abstract: A complementary DNA (cDNA) encoding full length form of ICErel-III is identified, sequenced and isolated. The cDNA is cloned into expression vectors for expression in recombinant hosts. The cDNA is useful to produce recombinant full length ICErel-III. The cDNA and the recombinant ICErel-III protein derived therefrom are useful in diagnostic kits, laboratory reagents and assays. The cDNA and the recombinant ICErel-III protein may be used to identify compounds that affect ICErel-III function, inflammation and cell apoptosis. ICErel-III function, inflammation and cell apoptosis may also be modulated by ICErel-III antisense or gene therapy.
Patent GR-3033840-T3 (GR)
Title: A reseal with a partial perforation and method and apparatus for creating a partial perforation in a reseal
Inventor: HELGREN R HAYES
IPC: B26D3/08
Filed: 2000-06-30
Abstract: A reseal is partially perforated by stretching the reseal membrane, establishing contact between one side of the membrane and an anvil, and by effecting partial penetration of the membrane with at least one cutting edge from the other side of the membrane to a predetermined distance from the anvil. Multiple partial perforations may be made with one or more cutting edges.
Patent GR-3033993-T3 (GR)
Title: N-benzylpiperazinderivatives, process for their preparation and pharmaceutical compositions containing them.
Inventor: WIERZBICKI MICHEL
IPC: A61K31/495
Filed: 2000-07-21
Abstract: The N-benzylpiperazine compounds of formula: <IMAGE>  in which R is as defined in the description. These new compounds and their physiologically tolerable acid addition salts can be used in therapeutics.
Patent GR-3036791-T3 (GR)
Title: Natural carob fibre and a procedure for its production.
Inventor: REQUEJO MARCO ANA MARIA
IPC: A23L33/22
Filed: 2001-10-03
Abstract: A natural carob fibre and a procedure for its production. The fibre comprises 50-65 % lignin, 15-25 % cellulose, 15-25 % hemicellulose, 0.5-2 % pectin, 3-7 % tannins and 4-8 % moisture. The procedure comprises the pressing of the waste pulp obtained in the operation of extracting the sugars from carob pulp.
Patent TR-201807416-T4 (TR)
Title: Prolaktin reseptörü bağlama proteinleri ve bunların kullanımları.
Inventor: MARK ANDERSON
IPC: A61K39/395
Filed: 2013-12-23
Abstract: Mevcut buluş, PRLR bağlama proteinlerini kapsar. Spesifik olarak, buluş kimerik, CDR grefte edilmiş ve hümanize antikorlar olan antikorlar ile ilgilidir. Tercih edilen antikorlar, hPRLR için yüksek afiniteye sahiptir ve hPRLR aktivitesini in vitro ve in vivo nötralize eder. Buluşun bir antikoru, bir tam-boy antikor veya bunun bir antijen-bağlama kısmı olabilir. Buluşun antikorlarını yapmanın yöntemleri veya kullanmanın yöntemleri de sağlanır. Buluşun antikorları veya antikor kısımları, örneğin, burada hPRLR aktivitesinin zararlı olduğu bir bozukluktan muzdarip olan bir insan süjesinde, hPRLR'yi saptamak için ve hPRLR aktivitesini inhibe etmek için yararlıdır. Anti-PRLR antikoru ilaç konjugatları (ADC'ler) de buluşa dahil edilir.
Patent TR-201901306-T4 (TR)
Title: Biyolojik madde numuneleri için fiksatif bileşim.
Inventor: CARMELO LUPO
IPC: G01N1/30
Filed: 2016-08-05
Abstract: Buluşun amacı, biyolojik madde numuneleri için, toksik olmayan ve büyük miktarlarda kolay ve güvenli bir şekilde kullanılabilen yeni bir fiksatif bileşimdir.
Patent TR-201906967-T4 (TR)
Title: Gecikmeli bir koklaşma prosesinden flaş alanı gaz yağının harici olarak işlenmesine yönelik sistemler ve yöntemler.
Inventor: Robert F Earhart
IPC: C10G9/00
Filed: 2014-03-12
Abstract: Gecikmeli koklaşma prosesine yeniden giriş yapmadan önce bir vakum çökelti hidro işleme birimi üzerinden yeniden işlenerek flaş alanı gaz yağının harici olarak işlenmesine yönelik sistemler ve yöntemlerdir.
Patent DE-10297714-T5 (DE)
Title: Prüfgerät für elektronische Bauelemente
Inventor: ITO AKIHIKO
IPC: G01R31/26
Filed: 2002-04-25
Abstract: Prüfgerät zur Prüfung elektronischer Bauelemente
(20) durch Andrücken
von Eingangs/Ausgangs-Kontakten der Bauelemente gegen Kontaktbereiche (110a;
600a) eines Prüfkopfes
(100) mit Hilfe einer Bewegungseinrichtung (201, 202), während die
zu prüfenden Bauelemente
(20) auf ein Fördermedium
(10; 701, 702) geladen sind, mit:  einer oder mehreren Bewegungseinrichtungen
(201, 202), die in der Lage sind, mehrere der mit zu prüfenden Bauelementen
(20) beladenen Fördermedien
(10; 701, 702) auf einmal aufzunehmen und zu den Kontaktbereichen
(110a; 600a) zuzuführen
und von diesen abzutransportieren.
Patent ES-2238963-T5 (ES)
Inventor: CHEN CHYI-CHENG
IPC: A61K9/51
Filed: 2000-11-27
Granted: 2017-04-04
Abstract: A powder composition containing at least one fat-soluble vitamin dispersed in a matrix of a natural polysaccharide gum or a mixture of gums having an emulsifying capacity and/or a protein or a mixture of proteins having an emulsifying capacity. The fat-soluble vitamin in the powder compositions is in the form of droplets having an average diameter in the range of about 70 to about 200 nm. Tablets, beverages and beverage concentrates, foods, cosmetics and pharmaceuticals containing the powder composition can be made.